131 related articles for article (PubMed ID: 11181205)
41. Lung deposition of budesonide from turbuhaler in asthmatic children.
Wildhaber JH; Devadason SG; Wilson JM; Roller C; Lagana T; Borgström L; LeSouëf PN
Eur J Pediatr; 1998 Dec; 157(12):1017-22. PubMed ID: 9877044
[TBL] [Abstract][Full Text] [Related]
42. Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.
Barnes CN; Mahler DA; Ohar JA; Lombardi DA; Crater GD
Chest; 2020 Oct; 158(4):1413-1419. PubMed ID: 32343967
[TBL] [Abstract][Full Text] [Related]
43. The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patients.
Persson G; Olsson B; Soliman S
Eur Respir J; 1997 Mar; 10(3):681-4. PubMed ID: 9073005
[TBL] [Abstract][Full Text] [Related]
44. Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.
Kawamatawong T; Khiawwan S; Pornsuriyasak P
J Asthma Allergy; 2017; 10():17-21. PubMed ID: 28260934
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
46. Reference values for forced inspiratory flows in children aged 7-15 years.
Tomalak W; Radliński J; Pogorzelski A; Doniec Z
Pediatr Pulmonol; 2004 Sep; 38(3):246-9. PubMed ID: 15274105
[TBL] [Abstract][Full Text] [Related]
47. Ability of preschool children to use dry powder inhalers as evaluated by In-Check Meter.
Adachi YS; Adachi Y; Itazawa T; Yamamoto J; Murakami G; Miyawaki T
Pediatr Int; 2006 Feb; 48(1):62-5. PubMed ID: 16490073
[TBL] [Abstract][Full Text] [Related]
48. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
49. [Patient preference in the choice of dry powder inhalers].
Giner J; Torrejón M; Ramos A; Casan P; Granel C; Plaza V; Belda J; Sanchis J
Arch Bronconeumol; 2004 Mar; 40(3):106-9. PubMed ID: 14998473
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.
Zimmerman B; D'Urzo A; Bérubé D
Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657
[TBL] [Abstract][Full Text] [Related]
51. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
52. [Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire].
Perpiñá Tordera M; Viejo JL; Sanchis J; Badia X; Cobos N; Picado C; Sobradillo V; Martínez González del Río J; Duce F; Muñoz Cabrera L
Arch Bronconeumol; 2008 Jul; 44(7):346-52. PubMed ID: 18727886
[TBL] [Abstract][Full Text] [Related]
53. [Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction].
Kokot M
Pol Merkur Lekarski; 2000 Oct; 9(52):672-6. PubMed ID: 11144054
[TBL] [Abstract][Full Text] [Related]
54. Lung deposition from the Turbuhaler in children with cystic fibrosis.
Devadason SG; Everard ML; MacEarlan C; Roller C; Summers QA; Swift P; Borgstrom L; Le Souëf PN
Eur Respir J; 1997 Sep; 10(9):2023-8. PubMed ID: 9311496
[TBL] [Abstract][Full Text] [Related]
55. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease.
Pleasants RA; Shaikh A; Henderson AG; Bayer V; Drummond MB
J Aerosol Med Pulm Drug Deliv; 2024 May; ():. PubMed ID: 38814000
[No Abstract] [Full Text] [Related]
56. Forced inspiratory flow volume curve in healthy young children.
Vilozni D; Efrati O; Barak A; Yahav Y; Augarten A; Bentur L
Pediatr Pulmonol; 2009 Feb; 44(2):105-11. PubMed ID: 19142889
[TBL] [Abstract][Full Text] [Related]
57. Inhaled therapy in elderly COPD patients; time for re-evaluation?
Jarvis S; Ind PW; Shiner RJ
Age Ageing; 2007 Mar; 36(2):213-8. PubMed ID: 17267450
[TBL] [Abstract][Full Text] [Related]
58. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
[TBL] [Abstract][Full Text] [Related]
59. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
Al-Showair RA; Tarsin WY; Assi KH; Pearson SB; Chrystyn H
Respir Med; 2007 Nov; 101(11):2395-401. PubMed ID: 17629471
[TBL] [Abstract][Full Text] [Related]
60. [Peak inspiratory flow during a diskhaler use in subjects unfamiliar with dry powder devices].
Kondo T; Tazaki G; Hirokawa Y; Tanigaki T; Ono Y; Ohta Y
Arerugi; 1999 Jun; 48(6):621-5. PubMed ID: 10423902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
